BIOPOD® LATEST CONCEPT COMBINES THE BEST IN HEARABLES AND WEARABLES TECHNOLOGY

As we see it, Wearables Technology Product companies are stuck with inadequate solutions”

— Richard J. Maertz, Inventor of BioPod Technology

LOS ANGELES , CALIFORNIA, USA, June 20, 2018 /EINPresswire.com/ — Meramark Ventures announces latest additions to growing Hearables Technology IP with USPTO publication of USPTO Patent # 9,782,084 (Issued October 10, 2017), and BioPod® Divisional Application and Claims published by the USPTO January 11, 2018.

BioPod® Technology’s latest concept, BioPod® 2 takes full advantage of the power of BioPod® Technology’s exclusive and proprietary IP, creating potential that is unheard of in current Wearables /Hearables technology and isn’t available on any other platform. “As we see it, Wearables Technology Product companies are stuck with inadequate solutions,” says Richard J. Maertz, Inventor of BioPod® Technology. He continues, “On one hand, you have the fitness band/watch category that lacks a full range of technical capability to provide important vitals data to their customers, while they are more convenient. Current Hearables technology has improved sensors and vitals data collecting capabilities and the ear offers superior biometric feedback capabilities to wrist mounted devices”

This disparity in products currently in the market provided an opportunity for BioPod® Technology to showcase what could possibly be the future of Wearables/Hearables Technology. We created an entirely new concept system that allows the best features of both worlds to be integrated into a singular system. Multi-function sensors provide ultimate flexibility for users and it’s unique design potential allows for a sleek and stylish solution that takes Wearable capabilities to a whole new level. Storage for the BioPod® EarPods is integrated into a watch/fitness band configuration that makes everything easily accessible. We’ve even added a hidden foldable display screen that folds away when not in use. The EarPods have dual configurations with a convenient compact design for general use and a telescoping Pro Boom attachment that provides Expressed CO2 monitoring for the ultimate capabilities for Pro-level athletes and future ones. It also provides remote respiratory care functions and monitoring right in your own home.

BioPod®’s Unique Patented Features

• Remote Patient and Athlete Monitoring • Secure Direct Communications with Healthcare Professionals, Caregivers, Family, Coaches, Trainers and more. • Data collected from ear sensors and other associated sensors includes: Heart Rate, Temperature, Oxygen Saturation, and End Tidal CO2.
• Data can be accessed continuously or intermittently with 24/7/365 direct communications available between users and a wide range of affiliates. • Audio Alerts and Haptic Feedback-enabled for real-time notifications for out of range high and low readings along with providing crucial communications such as prescription reminders, remote physical therapy and training data alerts, clinical trial regimen guidelines and much more!

BioPod® can be the conduit for additional sensors on the body of the user, both external and implanted sensors. Oxygen Saturation and Expressed CO2 are available through BioPod®’s patents and are crucial to all Healthcare and Homecare patients to properly determine lung function and provide remote monitoring for respiratory-challenged patients. Expressed CO2 is also a key indicator for Fitness and Sports training utilizing VO2 Max biometric readings to determine an individual’s oxygen intake and oxygen utilization. Expressed CO2 biometric readings are required to achieve these advanced calculations which are a key feature of BioPod® Technology’s patents and IP.

BioPod® offers a broad range of applications for the following fields: Healthcare/Homecare, IoMT, Fitness & Sport, Big Data, Smart Home, Military, Mixed Reality, and Video Gaming.

BioPod® is a registered trademark of Meramark Ventures, LLC. For more information or investor/partnership and licensing info, and BioPod® Technology presentation visit BioPod Tech Website and biopodventures.biopodtech.com or email us to arrange an appointment at: meramark@gmail.com.

Richard Maertz
Meramark Ventures
949-351-4376
email us here


Source: EIN Presswire

Iris Recognition Global Market Segmentation and key Players Analysis 2022

Iris Recognition Market 2018 – Current and Future Plans

PUNE, INDIA, June 20, 2018 /EINPresswire.com/ — The Global Iris Recognition Market statistical report, published by Market Research Future contains succinct information on the Iris Recognition market, segmented by product, components, applications, end-users and forecast from 2016-2022.

The factors driving the Iris Recognition market are Increasing Criminal activities at government and non-government sectors, and increasing implementation of iris recognition system at airports and super-markets.

The increasing implementation of 3D technology in microelectronic devices has reshaped the electronic market which is supporting growth of advanced packaging, MEMS and LED market in the region thereby expected to drive the Iris Recognition market. However, diversified European landscape has expected to hamper the market growth in the region during forecast period 2016-2022.

Europe Iris Recognition Market has dominated by UK and is expected to grow with 25% CAGR during forecast period 2016-2022

Table of Contents
1. Info graphics Information
1.1 Global Iris Recognition Market, by Europe, 2016-2022 (USD Million)
2. Global Iris Recognition Market by Europe, Market Data

List of Tables
Table 1 Global Iris Recognition Market, by Europe, 2016-2022 (USD Million)

List of Figures
Figure 1 Global Iris Recognition Market, by Europe, 2016-2022 (USD Million)

(Get our exclusive statistical reports at $299 only, for details, cordially enquire)
Enquire now: https://www.marketresearchfuture.com/statistical-reports/enquiry/3424

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Eosinophilic Esophagitis Drug Market 2018 Share, Trend, Segmentation and Forecast to 2023

Eosinophilic Esophagitis Drug Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

PUNE, MAHARASHTRA, INDIA, June 20, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Eosinophilic Esophagitis Drug Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Eosinophilic Esophagitis Drug Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Eosinophilic Esophagitis Drug Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn. 
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. 

Global Eosinophilic Esophagitis Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including 
AstraZeneca 
GSK 
Bayer 
Adare Pharmaceuticals 
DBV Technologies 
Dr. Falk Pharma 
Quorum Innovations 
Shire 
Calypso 
Celgene 
Regeneron

Market Segment as follows: 
By Region / Countries 
North America (U.S., Canada, Mexico) 
Europe (Germany, U.K., France, Italy, Russia, Spain etc) 
South America (Brazil, Argentina etc) 
Middle East & Africa (Saudi Arabia, South Africa etc) 

By Type 
Budesonide 
Fluticasone 
Others 

By End-User / Application 
Hospitals 
Clinics 
Drugstore 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3242317-2015-2023-world-eosinophilic-esophagitis-drug-market-research

Major Key Points in Table of Content

1 Market Definition 
1.1 Market Segment Overview 
1.2 by Type 
1.3 by End-Use / Application 

2 Global Market by Vendors 
2.1 Market Share 
2.2 Vendor Profile 
2.3 Dynamic of Vendors 

3 Global Market by Type 
3.1 Market Share 
3.2 Introduction of End-Use by Different Products 

4 Global Market by End-Use / Application 
4.1 Market Share 
4.2 Overview of Consumption Characteristics 
4.2.1 Preference Driven 
4.2.2 Substitutability 
4.2.3 Influence by Strategy 
4.2.4 Professional Needs 

5 Global Market by Regions 
5.1 Market Share 
5.2 Regional Market Growth 
5.2.1 North America 
5.2.2 Europe 
5.2.3 Asia-Pacific 
5.2.4 South America 
5.2.5 Middle East & Africa 

…..

12 Key Manufacturers 
12.1 AstraZeneca 
12.1.2 Company Overview 
12.1.2 Product and End-User / Application 
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.2 GSK 
12.2.1 Company Overview 
12.2.2 Product and End-User / Application 
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.3 Bayer 
12.3.1 Company Overview 
12.3.2 Product and End-User / Application 
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.4 Adare Pharmaceuticals 
12.4.1 Company Overview 
12.4.2 Product and End-User / Application 
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.5 DBV Technologies 
12.5.1 Company Overview 
12.5.2 Product and End-User / Application 
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.6 Dr. Falk Pharma 
12.12.1 Company Overview 
12.12.2 Product and End-User / Application 
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.7 Quorum Innovations 
12.7.1 Company Overview 
12.7.2 Product and End-User / Application 
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.8 Shire 
12.8.1 Company Overview 
12.8.2 Product and End-User / Application 
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.9 Calypso 
12.9.1 Company Overview 
12.9.2 Product and End-User / Application 
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.10 Celgene 
12.10.1 Company Overview 
12.10.2 Product and End-User / Application 
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) 
12.11 Regeneron 

At any Query @ https://www.wiseguyreports.com/enquiry/3242317-2015-2023-world-eosinophilic-esophagitis-drug-market-research

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Medical Tourism Market Research – Industry Analysis, Growth, Size, Share, Trends, Forecast to 2025

PUNE, INDIA, June 20, 2018 /EINPresswire.com/ — In this report, the global Medical Tourism market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Medical Tourism in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3065938-global-medical-tourism-market-research-report-2018

Global Medical Tourism market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Pantai Holdings Berhad
KPJ Healthcare Berhad
Dentalpro
Prince Court Medical Centre
Island Hospital
IJN Health Institute
Mahkota Medical Centre
Sunway Medical Centre
LohGuanLye Specialists Centre
Tropicana Medical Centre

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Cardio Internal Medicine
Cardiothoracic Surgery
Oncology
Fertility Treatments
Orthopedic Treatment
Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Application 1
Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Medical Tourism Market Research Report 2018
1 Medical Tourism Market Overview
1.1 Product Overview and Scope of Medical Tourism
1.2 Medical Tourism Segment by Type (Product Category)
1.2.1 Global Medical Tourism Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Medical Tourism Production Market Share by Type (Product Category) in 2017
1.2.3 Cardio Internal Medicine
1.2.4 Cardiothoracic Surgery
1.2.5 Oncology
1.2.6 Fertility Treatments
1.2.7 Orthopedic Treatment
1.2.8 Other
1.3 Global Medical Tourism Segment by Application
1.3.1 Medical Tourism Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Application 1
1.3.3 Application 2
1.4 Global Medical Tourism Market by Region (2013-2025)
1.4.1 Global Medical Tourism Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Medical Tourism (2013-2025)
1.5.1 Global Medical Tourism Revenue Status and Outlook (2013-2025)
1.5.2 Global Medical Tourism Capacity, Production Status and Outlook (2013-2025)

2 Global Medical Tourism Market Competition by Manufacturers
2.1 Global Medical Tourism Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Medical Tourism Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Medical Tourism Production and Share by Manufacturers (2013-2018)
2.2 Global Medical Tourism Revenue and Share by Manufacturers (2013-2018)
2.3 Global Medical Tourism Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Medical Tourism Manufacturing Base Distribution, Sales Area and Product Type
2.5 Medical Tourism Market Competitive Situation and Trends
2.5.1 Medical Tourism Market Concentration Rate
2.5.2 Medical Tourism Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Medical Tourism Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Medical Tourism Capacity and Market Share by Region (2013-2018)
3.2 Global Medical Tourism Production and Market Share by Region (2013-2018)
3.3 Global Medical Tourism Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Medical Tourism Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Medical Tourism Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Medical Tourism Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Medical Tourism Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Medical Tourism Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Medical Tourism Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Medical Tourism Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Medical Tourism Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Medical Tourism Consumption by Region (2013-2018)
4.2 North America Medical Tourism Production, Consumption, Export, Import (2013-2018)
4.3 Europe Medical Tourism Production, Consumption, Export, Import (2013-2018)
4.4 China Medical Tourism Production, Consumption, Export, Import (2013-2018)
4.5 Japan Medical Tourism Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Medical Tourism Production, Consumption, Export, Import (2013-2018)
4.7 India Medical Tourism Production, Consumption, Export, Import (2013-2018)

5 Global Medical Tourism Production, Revenue (Value), Price Trend by Type
5.1 Global Medical Tourism Production and Market Share by Type (2013-2018)
5.2 Global Medical Tourism Revenue and Market Share by Type (2013-2018)
5.3 Global Medical Tourism Price by Type (2013-2018)
5.4 Global Medical Tourism Production Growth by Type (2013-2018)

6 Global Medical Tourism Market Analysis by Application
6.1 Global Medical Tourism Consumption and Market Share by Application (2013-2018)
6.2 Global Medical Tourism Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

……Continued

Access Complete Report @ https://www.wiseguyreports.com/reports/3065938-global-medical-tourism-market-research-report-2018

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Food Grade & Pharma Grade Calcium Phosphate Market 2018 Share, Trend, Segmentation and Forecast to 2023

Food Grade & Pharma Grade Calcium Phosphate Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

PUNE, MAHARASHTRA, INDIA, June 20, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Food Grade & Pharma Grade Calcium Phosphate Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Food Grade & Pharma Grade Calcium Phosphate Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Food Grade & Pharma Grade Calcium Phosphate Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Calcium phosphate is a family of materials and minerals containing calcium ions (Ca2+) together with inorganic phosphate anions.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Global Food Grade & Pharma Grade Calcium Phosphate market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Innophos
Prayon
ICL PP
Chengxing Industrial
Hens
Budenheim
Tianjia Chem
Hindustan Phosphates
Thermphos
Kolod Food Ingredients
Gadot Biochemical
Haifa Group
Kede Food Ingredients
Sudeep Pharma

Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
TCP
DCP
MCP
Others

By End-User / Application
Food
Beverage
Pharma
Others 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3242324-2015-2023-world-food-grade-pharma-grade-calcium

Major Key Points in Table of Content

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

…..

12 Key Manufacturers
12.1 Innophos
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Prayon
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 ICL PP
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Chengxing Industrial
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Hens
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Budenheim
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Tianjia Chem
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Hindustan Phosphates
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Thermphos
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 Kolod Food Ingredients
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Gadot Biochemical
12.12 Haifa Group
12.13 Kede Food Ingredients
12.14 Sudeep Pharma 

At any Query @ https://www.wiseguyreports.com/enquiry/3242324-2015-2023-world-food-grade-pharma-grade-calcium

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

American Association of Suicidology’s Statement on the Detrimental Effects of Administration’s Family Separation Policy

This Administration’s 'zero-tolerance' policy will have irreparable consequences on thousands of children and families for decades to come.””

— Colleen Creighton

WASHINGTON, D.C., UNITED STATES, June 20, 2018 /EINPresswire.com/ — As the oldest membership-based suicide related organization in the United States, the American Association of Suicidology (AAS) is deeply concerned about the detrimental effects and long-term traumatic consequences of the current Administration’s “zero tolerance” policy of forcibly separating children from their parents at the US-Mexico border.

– Separation and isolation from one’s family increases the risk of suicide

– Separation from children, especially unexpected or through traumatic means, can increase the risk of suicide in parents

– Adverse Childhood Experiences (ACEs) have been shown to increase the risk of suicide throughout an individual’s lifespan

– Reports have surfaced that children in understaffed detention camps are attempting suicide with little to no access to mental healthcare or therapeutic support

Serious consequences of this new policy have become apparent as evidenced by at least one recent suicide of a parent in detainment and multiple reports of suicide attempts of adolescents in custody.

“As connectedness to family is a strong protective factor against the risk of suicide, this Administration’s 'zero-tolerance' policy will have irreparable consequences on thousands of children and families for decades to come,” said Colleen Creighton, Executive Director of AAS.

AAS strongly urges the Administration to re-evaluate and re-consider its current policy of forcibly separating children from their families at the US-Mexico border.

For the Media: Responsible reporting on suicide, including stories of hope and resilience, can prevent more suicides. Please visit the Reporting on Suicide guidelines for more information.

About AAS: Founded in 1968 by Edwin S. Shneidman, PhD, AAS promotes suicide as a research discipline, public awareness programs, public education and training for professionals and volunteers. The membership of AAS includes mental health and public health professionals, researchers, suicide prevention and crisis intervention centers, school districts, crisis center volunteers, survivors of suicide loss, attempt survivors, and a variety of lay persons who have in interest in suicide prevention. You can learn more about AAS at suicidology.org.

Colleen Creighton
American Association of Suicidology
202-237-2280
email us here


Source: EIN Presswire

Healthcare Software Defined Everything Global Market Share, Segmentation, Opportunities and Forecast to 2022

Healthcare Software Defined Everything Market 2018 Share, Trend, Segmentation and Forecast to 2022

PUNE, INDIA, June 20, 2018 /EINPresswire.com/ — The Software Defined Everything Market statistical report, published by Market Research Future contains succinct information on the software defined everything market. The various factors driving the software defined everything market are low cost of maintenance, high demand of cloud computing, growing application areas of software defined everything.

North America is dominating the market of Healthcare Software Defined Everything, By Region. North America has witnessed tremendous growth in the technology and adoption of cloud computing in banking and financial sector. Elimination of manual process in the banking sector is driving the market of HEALTHCARE software defined everything.

North America of Healthcare Software Defined Everything Market, By Region is expected to reach USD 15.21 Billion by 2022 with 36.88% of CAGR.

Table of Contents
Info graphics Information
List of Tables
Table 1 Healthcare Software Defined Everything Market, By Region, 2016-2022 (USD Billion) 4

List of Figures
Figure 1 Healthcare Software Defined Everything Market, By Region, 2016-2022 (USD Billion) …………..4
Figure 2 Healthcare Software Defined Everything Market, By Region, 2016-2022 (%) 5
Figure 3 Healthcare Software Defined Everything Market, By Region, 2016 vs 2022 (%) 6

(Get our exclusive statistical reports at $299 only, for details, cordially enquire)
Enquire now: https://www.marketresearchfuture.com/statistical-reports/enquiry/3412

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Tracheotomy Tube Market 2018 Share, Trend, Segmentation and Forecast to 2023

Tracheotomy Tube Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023

PUNE, MAHARASHTRA, INDIA, June 20, 2018 /EINPresswire.com/ — Summary

WiseGuyReports.com adds “Tracheotomy Tube Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Tracheotomy Tube Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Tracheotomy Tube Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

A commonly used tracheostomy tube consists of three parts: outer cannula with flange (neck plate), inner cannula, and an obturator. The outer cannula is the outer tube that holds the tracheostomy open. A neck plate extends from the sides of the outer tube and has holes to attach cloth ties or velcro strap around the neck. The inner cannula fits inside the outer cannula. It has a lock to keep it from being coughed out, and it is removed for cleaning. The obturator is used to insert a tracheostomy tube.  It fits inside the tube to provide a smooth surface that guides the tracheostomy tube when it is being inserted.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

Global Tracheotomy Tube market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Medtronic
Teleflex Medical
Smith's Medical
TRACOE Medical
ConvaTec
Fuji Systems
Sewoon Medical
Boston Medical
Well Lead
TuoRen
Pulmodyne

Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)

By Type
PVC Tracheostomy Tube
Silicone Rubber Tracheostomy Tube
Others

By End-User / Application
Emergency Treatment
Therapy 

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3242343-2015-2023-world-tracheotomy-tube-market-research-report

Major Key Points in Table of Content

1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs

5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa

…..

12 Key Manufacturers
12.1 Medtronic
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Teleflex Medical
12.2.1 Company Overview
12.2.2 Product and End-User / Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Smith's Medical
12.3.1 Company Overview
12.3.2 Product and End-User / Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 TRACOE Medical
12.4.1 Company Overview
12.4.2 Product and End-User / Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 ConvaTec
12.5.1 Company Overview
12.5.2 Product and End-User / Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Fuji Systems
12.12.1 Company Overview
12.12.2 Product and End-User / Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.7 Sewoon Medical
12.7.1 Company Overview
12.7.2 Product and End-User / Application
12.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.8 Boston Medical
12.8.1 Company Overview
12.8.2 Product and End-User / Application
12.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.9 Well Lead
12.9.1 Company Overview
12.9.2 Product and End-User / Application
12.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.10 TuoRen
12.10.1 Company Overview
12.10.2 Product and End-User / Application
12.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.11 Pulmodyne 

At any Query @ https://www.wiseguyreports.com/enquiry/3242343-2015-2023-world-tracheotomy-tube-market-research-report

Continued….

Contact Us: sales@wiseguyreports.com

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Biologics Logistics Outsourcing Market Growth Nearly Twice Other Pharma's

Global Bio-Pharmaceutical Logistics Outsourcing Market 2017

Global Bio-Pharmaceutical Logistics Outsourcing Market 2017

LONDON, GREATER LONDON, UK, June 20, 2018 /EINPresswire.com/ — The global market for logistics services for biologic drugs is growing at 7.6% year on year, a report from The Business Research Company shows, against just 4% for other pharmaceuticals. In both cases that represents an acceleration from their recent rates, but in the case of pharma generally it is a rise of less than 1 percentage point a year, compared with a more than doubling for biologics. As the chart shows, the biologics segment was worth only 19% of the total in 2017, but its faster growth rate will have that increase to 21% by 2021 and in some markets to even more. In the USA, for example, which will be worth over a quarter of the global total for all pharma logistics outsourcing in 2021, the biologics segment will account for 24%.

Drivers And Restraints Of The Biologics Logistics Market
Growth of the biologics logistics market is mainly driven by growth of the biologics market itself. Unlike small-molecule drugs that are manufactured through organic or inorganic chemical synthesis, biologics are manufactured by living cells. They are very large complex molecules manufactured in living systems such as microorganisms, animal cells or plant cells. They are produced using recombinant DNA technology and are composed of sugars, proteins, nucleic acids or a combination of these substances. Biologics are more complex, fragile and difficult to manufacture than small molecule drugs. They are, however, the best hope for treatment of many conditions including some cancers, rare diseases, neurological disorders, autoimmune disorders, heart disease and stroke, diabetes, mental health disorders and Alzheimer's. The global market for biologics is growing at 9.6% year on year, an increase from its recent growth of 5.4%.
It is this growth of the biologics market that is the main driver of growth in the related logistics market. Another driver is the increasing preference of pharmaceutical drugs manufacturers to outsource logistics to third-party logistics (3PL) companies in order to focus on their core business of drug development, manufacture and marketing. In addition, the complexity of logistics for pharma drugs in general and biologics in particular are important drivers. Vaccines, blood plasma products and drugs using genomic data have very particular requirements for their environment during transportation and warehousing. In the case of biologics the logistics system must be a 'cold-chain' (refrigerated) system that can ensure a supply of drugs to their point of use in a timely and cost-effective fashion, and also ensure that the key criteria of temperature control, regulatory compliance, security, safety and chain of custody are satisfied. Logistics companies that have developed special skills in and technology for these conditions are often able to provide a service that fulfils the requirements at lower cost than the pharma companies themselves.

Both the small-molecule pharmaceutical and the biologics logistics industries are expected to be negatively affected by shortages of skilled labor. Pharmaceutical logistics requires specialized skills. A shortage of specialized skill affects operational efficiency and profitability. Skill shortages in the logistics industry in general will also hamper growth of pharmaceutical logistics. According to the World Bank, logistics chains in both developed and developing countries suffer from skill shortages in qualified labor.

Where To Learn More
Read the Global Pharmaceutical Drugs And Biologics Logistics Market Report 2018 from The Business Research Company for information on the following:
Markets Covered: Pharmaceutical Drugs Logistics Market, Biologics Logistics Market, Pharmaceutical Drugs And Biologics Logistics Air, Sea and Land Transport Markets, Pharmaceutical Drugs And Biologics Cold-Chain and Non-Cold-Chain Logistics Markets
Pharmaceutical Drugs And Biologics Logistics Companies Covered: Deutsche Post DHL, FedEx Corporation, Panalpina World Transport, UPS, Kuehne + Nagel and DB Schenker
Regions: North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.
Countries: USA, China, Japan, Germany, Brazil, France, Italy, UK, Australia, India, Spain, Russia.
Time Series: Five years historic (2013-17) and forecast (2017-21).
Data: Pharmaceutical drugs logistics market, biologics logistics market and pharmaceutical drugs and biologics logistics market size and growth for 7 regions and 12 countries; global,regional and country pharmaceutical drugs and biologics logistics market size and growth segmented by type of service; global, regional and country pharmaceutical drugs and biologics logistics market size and growth segmented bymode of transport; global, regional and country pharmaceutical drugs and biologics logistics market per capita consumption and market size as a percentage of GDP 2013-21; Deutsche Post DHL, FedEx Corporation, Panalpina World Transport, UPS, Kuehne + Nagel and DB Schenker financial performance 2013-21.
Other Information: Porter's Five Forces Analysis of the Pharmaceutical Drugs And Biologics Logistics Market, PESTEL analysis of the Pharmaceutical Drugs And Biologics Logistics Market, drivers and restraints, customer and operational insights, pharmaceutical drugs and biologics logistics market by country covering opportunities, pharmaceutical drugs and biologics logistics associations, investment and expansion plans, corporate tax structure and competitive landscape; pharmaceutical drugs and biologics logistics market trends and strategies.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.
Related Reports:Biologics Global Market Report 2018
Pharmaceutical Drugs Global Market Report 2018

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here


Source: EIN Presswire

Challenges To Big Pharma Are Helping Drive The Bio-Pharmaceutical Logistics Market

Pharmaceutical And Biologistics Markets By Region 2017

Pharmaceutical And Biologistics Markets By Region 2017

LONDON , GREATER LONDON, UNITED KINGDOM, June 20, 2018 /EINPresswire.com/ — Pharmaceutical companies are trying to reduce their distribution costs to help compensate for pressures resulting from the increase of low-cost generics, the fall of the blockbuster drug model, and a sharp increase in R&D costs. One result is the growth of the bio-pharmaceutical logistics market, a report from The Business Research Company shows, as the pharma companies outsource their warehousing and transport functions. From a global value of $79.9 billion in 2017 the market is predicted to grow to $96 billion by 2020, at an annual growth rate of 4.7%. Some logistics providers, such as DHL, FedEx Corporation, Panalpina World Transport, and DB Schenker, have developed a special capability for the physical distribution of drugs. These businesses can cut costs by combining loads from a range of manufacturers, and by deploying technological solutions that also increase the visibility of the movement of the goods along their distribution path. Outsourcing to a logistics specialist that offers capability in logistics procedures can provide pharmaceutical manufacturers with sustainable lower cost levels and faster deliveries into the market.
Two factors in particular are supporting the growth of the pharmaceutical and biologics logistics market. One is increased sales of pharmaceutical drugs in general. Pharmaceutical products require an efficient logistics network for timely delivery of medicines to end users. The second factor is the rising production and sale of biologics. Vaccines, blood plasma products and drugs using genomic data have very particular requirements for their environment during transportation and warehousing. For example, the vaccine to protect against the Ebola virus requires storage at -80oc at all times until use. In the case of these biologics the logistics system must be a 'cold-chain' (refrigerated) system that can ensure a supply of drugs to their point of use in a timely and cost-effective fashion, and also ensure that the key criteria of temperature control, regulatory compliance, security, safety and chain of custody are satisfied.
“The major challenge for any company is to maintain the integrity of the product throughout the cold chain. You should have the right partnerships in order to move the freight flawlessly. The company must fulfil the logistics need of every customer in the market on every shipment.”
Global Account Director, DB Schenker, The Business Research Company primary research
Biologic products are higher-priced than small-molecule drugs and so allow a high-cost system for their delivery to patients. Higher value-per-unit biologics logistics services as well as growing volumes are supporting the rise of the overall market.

North America is the largest regional market for bio-pharmaceutical logistics, followed by Western Europe and Asia Pacific. The difference by region is most marked in the non cold-chain part of the market, where in 2017 the North American market exceeded the second largest region, Western Europe, by 84 percentage points. This segment, however, is growing more slowly than the cold-chain segment.

Where To Learn More
Read the Global Pharmaceutical Drugs And Biologics Logistics Market Report 2018 from The Business Research Company for information on the following:
Markets Covered: Pharmaceutical Drugs Logistics Market, Biologics Logistics Market, Pharmaceutical Drugs And Biologics Logistics Air, Sea and Land Transport Markets, Pharmaceutical Drugs And Biologics Cold-Chain and Non-Cold-Chain Logistics Markets
Pharmaceutical Drugs And Biologics Logistics Companies Covered: Deutsche Post DHL, FedEx Corporation, Panalpina World Transport, UPS, Kuehne + Nagel and DB Schenker
Regions: North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.
Countries: USA, China, Japan, Germany, Brazil, France, Italy, UK, Australia, India, Spain, Russia.
Time Series: Five years historic (2013-17) and forecast (2017-21).
Data: Pharmaceutical drugs logistics market, biologics logistics market and pharmaceutical drugs and biologics logistics market size and growth for 7 regions and 12 countries; global,regional and country pharmaceutical drugs and biologics logistics market size and growth segmented by type of service; global, regional and country pharmaceutical drugs and biologics logistics market size and growth segmented bymode of transport; global, regional and country pharmaceutical drugs and biologics logistics market per capita consumption and market size as a percentage of GDP 2013-21; Deutsche Post DHL, FedEx Corporation, Panalpina World Transport, UPS, Kuehne + Nagel and DB Schenker financial performance 2013-21.
Other Information: Porter's Five Forces Analysis of the Pharmaceutical Drugs And Biologics Logistics Market, PESTEL analysis of the Pharmaceutical Drugs And Biologics Logistics Market, drivers and restraints, customer and operational insights, pharmaceutical drugs and biologics logistics market by country covering opportunities, pharmaceutical drugs and biologics logistics associations, investment and expansion plans, corporate tax structure and competitive landscape; pharmaceutical drugs and biologics logistics market trends and strategies.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.
Related Reports:Biologics Global Market Report 2018
Pharmaceutical Drugs Global Market Report 2018

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here


Source: EIN Presswire